To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...
A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.
It seems like everyone and their sister is taking a GLP-1 (“glucagon-like peptide-1 receptor agonists,” if you’re feeling nasty), or is at least thinking about it. These meds—which include Ozempic, ...
10h
HealthDay on MSNRise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to 2023From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with type 1 diabetes, ...
India is facing a major health crisis, with rising obesity rates across all age groups, leading to increased early mortality ...
Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...
Real Housewives of New Jersey” star Jennifer Fessler didn’t follow her doctor’s advice when she started taking a GLP-1 weight ...
21h
MedPage Today on MSNSwitch to Tirzepatide in T2D More Effective Than Upping Dulaglutide DoseDiabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...
India faces a looming health crisis as obesity rates climb. The Good Bug introduces a pioneering Advanced Metabolic System, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results